PMC:7205724 / 21921-22249 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"761","span":{"begin":58,"end":63},"obj":"Species"},{"id":"762","span":{"begin":0,"end":11},"obj":"Chemical"},{"id":"763","span":{"begin":131,"end":150},"obj":"Disease"},{"id":"764","span":{"begin":194,"end":214},"obj":"Disease"},{"id":"765","span":{"begin":216,"end":236},"obj":"Disease"},{"id":"766","span":{"begin":238,"end":281},"obj":"Disease"},{"id":"767","span":{"begin":287,"end":327},"obj":"Disease"}],"attributes":[{"id":"A761","pred":"tao:has_database_id","subj":"761","obj":"Tax:9606"},{"id":"A762","pred":"tao:has_database_id","subj":"762","obj":"MESH:C502936"},{"id":"A763","pred":"tao:has_database_id","subj":"763","obj":"MESH:D001327"},{"id":"A764","pred":"tao:has_database_id","subj":"764","obj":"MESH:D001172"},{"id":"A765","pred":"tao:has_database_id","subj":"765","obj":"MESH:D013700"},{"id":"A766","pred":"tao:has_database_id","subj":"766","obj":"MESH:D001171"},{"id":"A767","pred":"tao:has_database_id","subj":"767","obj":"MESH:D001171"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T160","span":{"begin":77,"end":85},"obj":"Body_part"},{"id":"T161","span":{"begin":167,"end":175},"obj":"Body_part"},{"id":"T162","span":{"begin":222,"end":226},"obj":"Body_part"}],"attributes":[{"id":"A160","pred":"fma_id","subj":"T160","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A161","pred":"fma_id","subj":"T161","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A162","pred":"fma_id","subj":"T162","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T165","span":{"begin":131,"end":150},"obj":"Disease"},{"id":"T166","span":{"begin":194,"end":214},"obj":"Disease"},{"id":"T167","span":{"begin":205,"end":214},"obj":"Disease"},{"id":"T168","span":{"begin":216,"end":236},"obj":"Disease"},{"id":"T169","span":{"begin":227,"end":236},"obj":"Disease"},{"id":"T170","span":{"begin":238,"end":281},"obj":"Disease"},{"id":"T171","span":{"begin":252,"end":281},"obj":"Disease"},{"id":"T172","span":{"begin":272,"end":281},"obj":"Disease"},{"id":"T173","span":{"begin":298,"end":327},"obj":"Disease"},{"id":"T174","span":{"begin":318,"end":327},"obj":"Disease"}],"attributes":[{"id":"A165","pred":"mondo_id","subj":"T165","obj":"http://purl.obolibrary.org/obo/MONDO_0007179"},{"id":"A166","pred":"mondo_id","subj":"T166","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"},{"id":"A167","pred":"mondo_id","subj":"T167","obj":"http://purl.obolibrary.org/obo/MONDO_0005578"},{"id":"A168","pred":"mondo_id","subj":"T168","obj":"http://purl.obolibrary.org/obo/MONDO_0008538"},{"id":"A169","pred":"mondo_id","subj":"T169","obj":"http://purl.obolibrary.org/obo/MONDO_0043494"},{"id":"A170","pred":"mondo_id","subj":"T170","obj":"http://purl.obolibrary.org/obo/MONDO_0018456"},{"id":"A171","pred":"mondo_id","subj":"T171","obj":"http://purl.obolibrary.org/obo/MONDO_0011429"},{"id":"A172","pred":"mondo_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/MONDO_0005578"},{"id":"A173","pred":"mondo_id","subj":"T173","obj":"http://purl.obolibrary.org/obo/MONDO_0011429"},{"id":"A174","pred":"mondo_id","subj":"T174","obj":"http://purl.obolibrary.org/obo/MONDO_0005578"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T261","span":{"begin":41,"end":42},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T262","span":{"begin":43,"end":52},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T263","span":{"begin":58,"end":63},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T264","span":{"begin":222,"end":226},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T100","span":{"begin":142,"end":150},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"},{"id":"T101","span":{"begin":222,"end":226},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T216","span":{"begin":58,"end":63},"obj":"Species"}],"attributes":[{"id":"A216","pred":"ncbi_taxonomy_id","subj":"T216","obj":"NCBItxid:9606"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T179","span":{"begin":0,"end":328},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"762","span":{"begin":0,"end":11},"obj":"Chemical"},{"id":"761","span":{"begin":58,"end":63},"obj":"Species"},{"id":"763","span":{"begin":131,"end":150},"obj":"Disease"},{"id":"764","span":{"begin":194,"end":214},"obj":"Disease"},{"id":"765","span":{"begin":216,"end":236},"obj":"Disease"},{"id":"766","span":{"begin":238,"end":281},"obj":"Disease"},{"id":"767","span":{"begin":287,"end":327},"obj":"Disease"}],"attributes":[{"id":"A762","pred":"pubann:denotes","subj":"762","obj":"MESH:C502936"},{"id":"A761","pred":"pubann:denotes","subj":"761","obj":"Tax:9606"},{"id":"A763","pred":"pubann:denotes","subj":"763","obj":"MESH:D001327"},{"id":"A764","pred":"pubann:denotes","subj":"764","obj":"MESH:D001172"},{"id":"A765","pred":"pubann:denotes","subj":"765","obj":"MESH:D013700"},{"id":"A766","pred":"pubann:denotes","subj":"766","obj":"MESH:D001171"},{"id":"A767","pred":"pubann:denotes","subj":"767","obj":"MESH:D001171"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T2117","span":{"begin":64,"end":67},"obj":"Protein"}],"attributes":[{"id":"A2117","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q9XT80"},{"id":"A2118","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q9UCU4"},{"id":"A2119","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q9UCU3"},{"id":"A2120","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q9UCU2"},{"id":"A2121","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q9MZR1"},{"id":"A2122","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q9MYZ7"},{"id":"A2123","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q95KN6"},{"id":"A2124","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q95181"},{"id":"A2125","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q90YI0"},{"id":"A2126","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q8MKH0"},{"id":"A2127","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q8BN26"},{"id":"A2128","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q865X6"},{"id":"A2129","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q865W7"},{"id":"A2130","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q6V919"},{"id":"A2131","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q6L6X6"},{"id":"A2132","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q5I6E3"},{"id":"A2133","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q3UCQ0"},{"id":"A2134","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q2MH06"},{"id":"A2135","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q28819"},{"id":"A2136","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q28747"},{"id":"A2137","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q28319"},{"id":"A2138","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q25BC2"},{"id":"A2139","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q0PW36"},{"id":"A2140","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q0GGL7"},{"id":"A2141","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/Q08DT2"},{"id":"A2142","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P79341"},{"id":"A2143","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P51494"},{"id":"A2144","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P46650"},{"id":"A2145","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P41693"},{"id":"A2146","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P41683"},{"id":"A2147","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P41323"},{"id":"A2148","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P29455"},{"id":"A2149","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P26893"},{"id":"A2150","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P26892"},{"id":"A2151","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P20607"},{"id":"A2152","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P08505"},{"id":"A2153","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/P05231"},{"id":"A2154","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/O46568"},{"id":"A2155","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/O35736"},{"id":"A2156","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/O19007"},{"id":"A2157","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/B6CKP4"},{"id":"A2158","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/A9QWQ9"},{"id":"A2159","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/A3FBE9"},{"id":"A2160","pred":"uniprot_id","subj":"T2117","obj":"https://www.uniprot.org/uniprot/A0S0B0"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T86439","span":{"begin":0,"end":11},"obj":"NNP"},{"id":"T21494","span":{"begin":11,"end":12},"obj":"-COMMA-"},{"id":"T50157","span":{"begin":13,"end":17},"obj":"RB"},{"id":"T26283","span":{"begin":18,"end":23},"obj":"VBN"},{"id":"T43571","span":{"begin":24,"end":26},"obj":"IN"},{"id":"T44785","span":{"begin":27,"end":36},"obj":"NN"},{"id":"T96810","span":{"begin":36,"end":37},"obj":"-COMMA-"},{"id":"T58761","span":{"begin":38,"end":40},"obj":"VBZ"},{"id":"T56416","span":{"begin":41,"end":42},"obj":"DT"},{"id":"T79548","span":{"begin":43,"end":52},"obj":"JJ"},{"id":"T29074","span":{"begin":53,"end":63},"obj":"JJ"},{"id":"T88685","span":{"begin":64,"end":67},"obj":"NN"},{"id":"T26777","span":{"begin":68,"end":76},"obj":"NN"},{"id":"T24185","span":{"begin":77,"end":85},"obj":"NN"},{"id":"T17221","span":{"begin":86,"end":94},"obj":"VBN"},{"id":"T32471","span":{"begin":95,"end":97},"obj":"IN"},{"id":"T53882","span":{"begin":98,"end":101},"obj":"NNP"},{"id":"T24580","span":{"begin":102,"end":105},"obj":"IN"},{"id":"T33924","span":{"begin":106,"end":113},"obj":"JJ"},{"id":"T90119","span":{"begin":114,"end":126},"obj":"JJ"},{"id":"T59846","span":{"begin":127,"end":130},"obj":"CC"},{"id":"T31666","span":{"begin":131,"end":141},"obj":"JJ"},{"id":"T46803","span":{"begin":142,"end":150},"obj":"NNS"},{"id":"T80969","span":{"begin":151,"end":157},"obj":"JJ"},{"id":"T13017","span":{"begin":157,"end":158},"obj":"-COMMA-"},{"id":"T79015","span":{"begin":159,"end":163},"obj":"JJ"},{"id":"T43255","span":{"begin":164,"end":166},"obj":"IN"},{"id":"T47553","span":{"begin":167,"end":175},"obj":"NN"},{"id":"T34694","span":{"begin":176,"end":183},"obj":"NN"},{"id":"T36705","span":{"begin":184,"end":192},"obj":"NN"},{"id":"T68837","span":{"begin":192,"end":193},"obj":"-COMMA-"},{"id":"T30269","span":{"begin":194,"end":204},"obj":"JJ"},{"id":"T54700","span":{"begin":205,"end":214},"obj":"NN"},{"id":"T81658","span":{"begin":214,"end":215},"obj":"-COMMA-"},{"id":"T84650","span":{"begin":216,"end":221},"obj":"JJ"},{"id":"T11095","span":{"begin":222,"end":226},"obj":"NN"},{"id":"T15987","span":{"begin":227,"end":236},"obj":"NN"},{"id":"T88887","span":{"begin":236,"end":237},"obj":"-COMMA-"},{"id":"T31599","span":{"begin":238,"end":251},"obj":"JJ"},{"id":"T93322","span":{"begin":252,"end":260},"obj":"JJ"},{"id":"T49595","span":{"begin":261,"end":271},"obj":"JJ"},{"id":"T62141","span":{"begin":272,"end":281},"obj":"NN"},{"id":"T76737","span":{"begin":281,"end":282},"obj":"-COMMA-"},{"id":"T30470","span":{"begin":283,"end":286},"obj":"CC"},{"id":"T13999","span":{"begin":287,"end":297},"obj":"JJ"},{"id":"T88238","span":{"begin":298,"end":306},"obj":"JJ"},{"id":"T89892","span":{"begin":307,"end":317},"obj":"JJ"},{"id":"T97598","span":{"begin":318,"end":327},"obj":"NN"}],"relations":[{"id":"R83125","pred":"arg1Of","subj":"T86439","obj":"T21494"},{"id":"R13146","pred":"arg1Of","subj":"T26283","obj":"T50157"},{"id":"R82868","pred":"arg2Of","subj":"T86439","obj":"T26283"},{"id":"R76811","pred":"arg1Of","subj":"T26283","obj":"T43571"},{"id":"R6462","pred":"arg2Of","subj":"T44785","obj":"T43571"},{"id":"R65301","pred":"arg1Of","subj":"T58761","obj":"T96810"},{"id":"R91756","pred":"arg1Of","subj":"T86439","obj":"T58761"},{"id":"R48338","pred":"arg2Of","subj":"T24185","obj":"T58761"},{"id":"R19276","pred":"arg1Of","subj":"T24185","obj":"T56416"},{"id":"R24087","pred":"arg1Of","subj":"T24185","obj":"T79548"},{"id":"R65895","pred":"arg1Of","subj":"T24185","obj":"T29074"},{"id":"R2263","pred":"arg1Of","subj":"T24185","obj":"T88685"},{"id":"R21524","pred":"arg1Of","subj":"T24185","obj":"T26777"},{"id":"R18021","pred":"arg1Of","subj":"T53882","obj":"T17221"},{"id":"R77534","pred":"arg2Of","subj":"T24185","obj":"T17221"},{"id":"R58214","pred":"arg2Of","subj":"T53882","obj":"T32471"},{"id":"R27887","pred":"arg1Of","subj":"T17221","obj":"T24580"},{"id":"R20734","pred":"arg2Of","subj":"T80969","obj":"T24580"},{"id":"R13465","pred":"arg1Of","subj":"T46803","obj":"T33924"},{"id":"R86212","pred":"arg1Of","subj":"T46803","obj":"T90119"},{"id":"R60939","pred":"arg1Of","subj":"T90119","obj":"T59846"},{"id":"R4444","pred":"arg2Of","subj":"T31666","obj":"T59846"},{"id":"R87485","pred":"arg1Of","subj":"T46803","obj":"T31666"},{"id":"R90538","pred":"arg1Of","subj":"T46803","obj":"T80969"},{"id":"R97819","pred":"arg1Of","subj":"T17221","obj":"T13017"},{"id":"R24341","pred":"arg1Of","subj":"T43255","obj":"T79015"},{"id":"R92610","pred":"arg1Of","subj":"T24185","obj":"T43255"},{"id":"R33248","pred":"arg2Of","subj":"T30470","obj":"T43255"},{"id":"R45357","pred":"arg1Of","subj":"T36705","obj":"T47553"},{"id":"R21959","pred":"arg1Of","subj":"T36705","obj":"T34694"},{"id":"R41949","pred":"arg1Of","subj":"T36705","obj":"T68837"},{"id":"R19260","pred":"arg2Of","subj":"T54700","obj":"T68837"},{"id":"R59437","pred":"arg1Of","subj":"T54700","obj":"T30269"},{"id":"R79844","pred":"arg1Of","subj":"T68837","obj":"T81658"},{"id":"R96846","pred":"arg2Of","subj":"T15987","obj":"T81658"},{"id":"R42046","pred":"arg1Of","subj":"T15987","obj":"T84650"},{"id":"R12475","pred":"arg1Of","subj":"T15987","obj":"T11095"},{"id":"R20864","pred":"arg1Of","subj":"T81658","obj":"T88887"},{"id":"R12170","pred":"arg2Of","subj":"T62141","obj":"T88887"},{"id":"R2759","pred":"arg1Of","subj":"T62141","obj":"T31599"},{"id":"R56313","pred":"arg1Of","subj":"T62141","obj":"T93322"},{"id":"R57671","pred":"arg1Of","subj":"T62141","obj":"T49595"},{"id":"R19638","pred":"arg1Of","subj":"T30470","obj":"T76737"},{"id":"R50655","pred":"arg1Of","subj":"T88887","obj":"T30470"},{"id":"R47508","pred":"arg2Of","subj":"T97598","obj":"T30470"},{"id":"R2665","pred":"arg1Of","subj":"T97598","obj":"T13999"},{"id":"R42821","pred":"arg1Of","subj":"T97598","obj":"T88238"},{"id":"R23852","pred":"arg1Of","subj":"T97598","obj":"T89892"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T160","span":{"begin":77,"end":85},"obj":"Body_part"},{"id":"T161","span":{"begin":167,"end":175},"obj":"Body_part"},{"id":"T162","span":{"begin":222,"end":226},"obj":"Body_part"}],"attributes":[{"id":"A160","pred":"fma_id","subj":"T160","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A161","pred":"fma_id","subj":"T161","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A162","pred":"fma_id","subj":"T162","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T160","span":{"begin":131,"end":150},"obj":"Disease"},{"id":"T161","span":{"begin":194,"end":214},"obj":"Disease"},{"id":"T162","span":{"begin":216,"end":236},"obj":"Disease"},{"id":"T163","span":{"begin":238,"end":281},"obj":"Disease"},{"id":"T164","span":{"begin":298,"end":327},"obj":"Disease"}],"attributes":[{"id":"A160","pred":"mondo_id","subj":"T160","obj":"http://purl.obolibrary.org/obo/MONDO_0007179"},{"id":"A161","pred":"mondo_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"},{"id":"A162","pred":"mondo_id","subj":"T162","obj":"http://purl.obolibrary.org/obo/MONDO_0008538"},{"id":"A163","pred":"mondo_id","subj":"T163","obj":"http://purl.obolibrary.org/obo/MONDO_0018456"},{"id":"A164","pred":"mondo_id","subj":"T164","obj":"http://purl.obolibrary.org/obo/MONDO_0011429"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T9","span":{"begin":131,"end":150},"obj":"Phenotype"},{"id":"T10","span":{"begin":194,"end":214},"obj":"Phenotype"},{"id":"T11","span":{"begin":227,"end":236},"obj":"Phenotype"},{"id":"T12","span":{"begin":252,"end":281},"obj":"Phenotype"},{"id":"T13","span":{"begin":298,"end":327},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002960"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0001370"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0012089"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0005681"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0005681"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}

{"project":"LitCovid-sentences","denotations":[{"id":"T179","span":{"begin":0,"end":328},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":131,"end":150},"obj":"Phenotype"},{"id":"T10","span":{"begin":167,"end":192},"obj":"Phenotype"},{"id":"T11","span":{"begin":194,"end":214},"obj":"Phenotype"},{"id":"T12","span":{"begin":227,"end":236},"obj":"Phenotype"},{"id":"T13","span":{"begin":252,"end":281},"obj":"Phenotype"},{"id":"T14","span":{"begin":298,"end":327},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002960"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0033041"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0001370"},{"id":"A12","pred":"hp_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/HP_0012089"},{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0005681"},{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0005681"}],"text":"Tocilizumab, also known as atlizumab, is a humanized anti-human IL6 receptor antibody approved by FDA for several inflammatory and autoimmune diseases severe, such as cytokine release syndrome, rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, and systematic juvenile idiopathic arthritis."}